369 related articles for article (PubMed ID: 34619561)
1. Cells, scaffolds, and bioactive factors: Engineering strategies for improving regeneration following volumetric muscle loss.
Eugenis I; Wu D; Rando TA
Biomaterials; 2021 Nov; 278():121173. PubMed ID: 34619561
[TBL] [Abstract][Full Text] [Related]
2. Skeletal Muscle Tissue Engineering: Biomaterials-Based Strategies for the Treatment of Volumetric Muscle Loss.
Carnes ME; Pins GD
Bioengineering (Basel); 2020 Jul; 7(3):. PubMed ID: 32751847
[TBL] [Abstract][Full Text] [Related]
3. Biomimetic scaffolds for regeneration of volumetric muscle loss in skeletal muscle injuries.
Grasman JM; Zayas MJ; Page RL; Pins GD
Acta Biomater; 2015 Oct; 25():2-15. PubMed ID: 26219862
[TBL] [Abstract][Full Text] [Related]
4. Vascularized and Innervated Skeletal Muscle Tissue Engineering.
Gilbert-Honick J; Grayson W
Adv Healthc Mater; 2020 Jan; 9(1):e1900626. PubMed ID: 31622051
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Evaluation of Functional Outcomes Following Rat Volumetric Muscle Loss Injury and Repair.
Mintz EL; Passipieri JA; Franklin IR; Toscano VM; Afferton EC; Sharma PR; Christ GJ
Tissue Eng Part A; 2020 Feb; 26(3-4):140-156. PubMed ID: 31578935
[TBL] [Abstract][Full Text] [Related]
6. Implantation of in vitro tissue engineered muscle repair constructs and bladder acellular matrices partially restore in vivo skeletal muscle function in a rat model of volumetric muscle loss injury.
Corona BT; Ward CL; Baker HB; Walters TJ; Christ GJ
Tissue Eng Part A; 2014 Feb; 20(3-4):705-15. PubMed ID: 24066899
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulation and Biomaterials: Key Players to Repair Volumetric Muscle Loss.
Kiran S; Dwivedi P; Kumar V; Price RL; Singh UP
Cells; 2021 Aug; 10(8):. PubMed ID: 34440785
[TBL] [Abstract][Full Text] [Related]
8. Aerobic exercise and scaffolds with hierarchical porosity synergistically promote functional recovery post volumetric muscle loss.
Endo Y; Samandari M; Karvar M; Mostafavi A; Quint J; Rinoldi C; Yazdi IK; Swieszkowski W; Mauney J; Agarwal S; Tamayol A; Sinha I
Biomaterials; 2023 May; 296():122058. PubMed ID: 36841214
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of adipose-derived stem cells for tissue-engineered muscle repair construct-mediated repair of a murine model of volumetric muscle loss injury.
Kesireddy V
Int J Nanomedicine; 2016; 11():1461-73. PubMed ID: 27114706
[TBL] [Abstract][Full Text] [Related]
10. Scalable macroporous hydrogels enhance stem cell treatment of volumetric muscle loss.
Eugenis I; Wu D; Hu C; Chiang G; Huang NF; Rando TA
Biomaterials; 2022 Nov; 290():121818. PubMed ID: 36209578
[TBL] [Abstract][Full Text] [Related]
11. Engineering muscle constructs for the creation of functional engineered musculoskeletal tissue.
Mertens JP; Sugg KB; Lee JD; Larkin LM
Regen Med; 2014 Jan; 9(1):89-100. PubMed ID: 24351009
[TBL] [Abstract][Full Text] [Related]
12. A tissue engineering approach for repairing craniofacial volumetric muscle loss in a sheep following a 2, 4, and 6-month recovery.
Rodriguez BL; Vega-Soto EE; Kennedy CS; Nguyen MH; Cederna PS; Larkin LM
PLoS One; 2020; 15(9):e0239152. PubMed ID: 32956427
[TBL] [Abstract][Full Text] [Related]
13. Regenerative medicine for skeletal muscle loss: a review of current tissue engineering approaches.
Langridge B; Griffin M; Butler PE
J Mater Sci Mater Med; 2021 Jan; 32(1):15. PubMed ID: 33475855
[TBL] [Abstract][Full Text] [Related]
14. Advances in electrospinning and 3D bioprinting strategies to enhance functional regeneration of skeletal muscle tissue.
Thangadurai M; Ajith A; Budharaju H; Sethuraman S; Sundaramurthi D
Biomater Adv; 2022 Nov; 142():213135. PubMed ID: 36215745
[TBL] [Abstract][Full Text] [Related]
15. Bioengineered constructs combined with exercise enhance stem cell-mediated treatment of volumetric muscle loss.
Quarta M; Cromie M; Chacon R; Blonigan J; Garcia V; Akimenko I; Hamer M; Paine P; Stok M; Shrager JB; Rando TA
Nat Commun; 2017 Jun; 8():15613. PubMed ID: 28631758
[TBL] [Abstract][Full Text] [Related]
16. An acellular biologic scaffold does not regenerate appreciable de novo muscle tissue in rat models of volumetric muscle loss injury.
Aurora A; Roe JL; Corona BT; Walters TJ
Biomaterials; 2015 Oct; 67():393-407. PubMed ID: 26256250
[TBL] [Abstract][Full Text] [Related]
17. Engineering functional and histological regeneration of vascularized skeletal muscle.
Gilbert-Honick J; Iyer SR; Somers SM; Lovering RM; Wagner K; Mao HQ; Grayson WL
Biomaterials; 2018 May; 164():70-79. PubMed ID: 29499437
[TBL] [Abstract][Full Text] [Related]
18. Acellular collagen-glycosaminoglycan matrix promotes functional recovery in a rat model of volumetric muscle loss.
Zhu C; Karvar M; Koh DJ; Sklyar K; Endo Y; Quint J; Samandari M; Tamayol A; Sinha I
Regen Med; 2023 Aug; 18(8):623-633. PubMed ID: 37491948
[TBL] [Abstract][Full Text] [Related]
19. The Potential of Combination Therapeutics for More Complete Repair of Volumetric Muscle Loss Injuries: The Role of Exogenous Growth Factors and/or Progenitor Cells in Implantable Skeletal Muscle Tissue Engineering Technologies.
Passipieri JA; Christ GJ
Cells Tissues Organs; 2016; 202(3-4):202-213. PubMed ID: 27825153
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceutical Agents for Contractile-Metabolic Dysfunction After Volumetric Muscle Loss.
McFaline-Figueroa J; Schifino AG; Nichenko AS; Lord MN; Hunda ET; Winders EA; Noble EE; Greising SM; Call JA
Tissue Eng Part A; 2022 Sep; 28(17-18):795-806. PubMed ID: 35620911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
